From the recent paper from Furyk in the EMJ on oral and i.v. paracetamol, does the fact that the study was underpowered mean a greater chance of a type 2 error?

References and relevant resources

http://CriticalAppraisalLowdown.co.uk

http://theresusroom.co.uk/papers-of-january-18